These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

117 related articles for article (PubMed ID: 2836313)

  • 1. Hepatitis A in young Norwegian drug addicts and prison inmates.
    Holter E; Siebke JC
    Infection; 1988; 16(2):91-4. PubMed ID: 2836313
    [TBL] [Abstract][Full Text] [Related]  

  • 2. An investigation of the potential risk of an HAV outbreak in a prison population following the introduction of cases from a community outbreak.
    Skidmore S; Parry JV; Nottage P
    Commun Dis Public Health; 2001 Jun; 4(2):133-5. PubMed ID: 11525002
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Prevalence and determinants of hepatitis A virus exposure among prison entrants in Queensland, Australia: implications for public health control.
    Whiteman D; McCall B; Falconer A
    J Viral Hepat; 1998 Jul; 5(4):277-83. PubMed ID: 9751015
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Increased occurrence of hepatitis A with cyclic outbreaks among drug addicts in a Swedish community.
    Widell A; Hansson BG; Moestrup T; Nordenfelt E
    Infection; 1983; 11(4):198-200. PubMed ID: 6618674
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Seroepidemiology of hepatitis A in Tennessee prisoners.
    Decker MD; Vaughn WK; Brodie JS; Hutcheson RH; Schaffner W
    J Infect Dis; 1984 Sep; 150(3):460. PubMed ID: 6090543
    [No Abstract]   [Full Text] [Related]  

  • 6. [Hepatitis A-, B- and C-markers among Norwegian drug addicts in the period 1975-89].
    Kielland KB; Siebke JC
    Tidsskr Nor Laegeforen; 1991 Mar; 111(7):821-4. PubMed ID: 1902331
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Prevalence of markers of hepatotropic viruses among drug addicts in Warsaw, Poland.
    Laskus T; Radkowski M; Lupa E; Slusarczyk J; Cianciara J; Halama G; Nowicka R
    J Hepatol; 1992 May; 15(1-2):114-7. PubMed ID: 1324268
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Markers of hepatitis A infection in drug addicts].
    Laskus T; Radkowski M; Lupa E; Cianciara J; Slusarczyk J
    Pol Tyg Lek; 1993 Mar 15-29; 48(11-13):261-2. PubMed ID: 8234038
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Seroepidemiology of hepatitis A virus infection in medical and nursing students. The role of vaccination].
    Buti M; Campins M; Jardí R; Navas E; Cotrina M; Llobet E; Vaqué J; Esteban R
    Gastroenterol Hepatol; 1996 Apr; 19(4):199-202. PubMed ID: 8665357
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Current seroepidemiological status of hepatitis A with a comparison of antibody titers after infection and vaccination.
    Fujiyama S; Odoh K; Kuramoto I; Mizuno K; Tsurusaki R; Sato T
    J Hepatol; 1994 Oct; 21(4):641-5. PubMed ID: 7814811
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [The relationship between changing of anti-HAV in population and prevalence of hepatitis A].
    Li L
    Zhonghua Yu Fang Yi Xue Za Zhi; 1989 May; 23(3):139-40. PubMed ID: 2555117
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Prevalence of hepatitis A, B, C virus markers in Réunion (south hospital and Saint Pierre prison)].
    Michault A; Faulques B; Sevadjan B; Troalen D; Marais A; Barau G
    Bull Soc Pathol Exot; 2000 Feb; 93(1):34-40. PubMed ID: 10774493
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Prevalence of hepatitis A antibodies in polytransfused thalassemic patients].
    Mangiagli A
    Pediatr Med Chir; 1997; 19(6):437-8. PubMed ID: 9595581
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [The prevalence of markers for the hepatitis A and B viruses in the population of Gijón between 6 and 25 years old].
    Suárez A; Navascués CA; García R; Peredo B; Miguel D; Menéndez MT; Saro C; Román F
    Med Clin (Barc); 1996 Apr; 106(13):491-4. PubMed ID: 8992130
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Prevalence of antibodies against hepatitis A virus, hepatitis B virus, and Treponema pallidum in Mauritius.
    Schwarz TF; Kam CC; Min GL; Jilg W; Wilske B; Gürtler L; Deinhardt F
    Scand J Infect Dis; 1991; 23(5):535-41. PubMed ID: 1662829
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Declining prevalence of antibodies to hepatitis A virus infection in Iceland.
    Briem H
    Scand J Infect Dis; 1991; 23(2):135-8. PubMed ID: 1649491
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Risk factors and prevalence of antibodies against hepatitis A virus (HAV) in children from day-care centers, in Goiania, Brazil.
    Queiróz DA; Cardoso DD; Martelli CM; Martins RM; Porto SO; Borges AM; Azevedo MS; Daher RR
    Rev Inst Med Trop Sao Paulo; 1995; 37(5):427-33. PubMed ID: 8729753
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Revisiting the Holy Cross football team hepatitis outbreak (1969) by serological analysis.
    Friedman LS; O'Brien TF; Morse LJ; Chang LW; Wacker WE; Ryan DM; Dienstag JL
    JAMA; 1985 Aug; 254(6):774-6. PubMed ID: 2989569
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Simultaneous detection of IgM antibodies against the hepatitis A virus and the viral capsid antigen of Epstein-Barr virus in acute hepatitis].
    Naveau S; Delfraissy JF; Poitrine A; Poynard T; Chaput JC
    Gastroenterol Clin Biol; 1985 Feb; 9(2):109-12. PubMed ID: 2984075
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Viral hepatitis A: causes of lingering].
    Vinogradova EN; Iakovlev AA; Demidenko TP
    Klin Med (Mosk); 1996; 74(9):29-31. PubMed ID: 9121083
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.